Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4.
ginkgolic acid
migration
oral squamous cell carcinoma
proliferation
small ubiquitin-like modifiers
Journal
Molecular therapy oncolytics
ISSN: 2372-7705
Titre abrégé: Mol Ther Oncolytics
Pays: United States
ID NLM: 101666776
Informations de publication
Date de publication:
27 Mar 2020
27 Mar 2020
Historique:
received:
02
04
2019
accepted:
07
12
2019
entrez:
24
1
2020
pubmed:
24
1
2020
medline:
24
1
2020
Statut:
epublish
Résumé
Small ubiquitin-related modifiers (SUMO) represent a class of ubiquitin-like proteins that are conjugated, like ubiquitin, by a set of enzymes to form cellular regulatory proteins, and play key roles in the control of cell proliferation, differentiation, and apoptosis. We found that ginkgolic acid (GA) can significantly reduce cell vitality in a dose- and time-dependent manner and can also accelerate cyto-apoptosis in both Tca8113 and Cal-27 cells. Migration and wound-healing assays were executed to determine the anti-migration effect of GA in oral squamous cell carcinoma (OSCC) cell lines. GA represses transforming growth factor-β1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT) markers in OSCC cell lines. This investigation is the first evidence that GA suppresses TGF-β1-induced SUMOylation of SMAD4. We show that GA affects the phosphorylation of SMAD2/3 protein and the release of SMAD4. In the xenograft mouse model, the OSCC progression was reduced by GA, effectively suppressing the growth of tumors. In addition, si
Identifiants
pubmed: 31970286
doi: 10.1016/j.omto.2019.12.005
pii: S2372-7705(19)30106-8
pmc: PMC6965518
doi:
Types de publication
Journal Article
Langues
eng
Pagination
86-99Informations de copyright
© 2019 The Author(s).
Références
J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8
pubmed: 22380770
Ann N Y Acad Sci. 1999 Jun 30;880:31-7
pubmed: 10415848
Nurs Manage. 1989 Feb;20(2):46-8
pubmed: 2922166
Int J Oncol. 2007 Sep;31(3):517-24
pubmed: 17671677
J Biol Chem. 2003 Jul 25;278(30):27853-63
pubmed: 12740389
Science. 1996 Jan 19;271(5247):350-3
pubmed: 8553070
Mol Carcinog. 2007 Aug;46(8):585-90
pubmed: 17626251
J Cell Physiol. 2017 Feb;232(2):346-354
pubmed: 27177359
Oral Oncol. 2012 Jun;48(6):500-6
pubmed: 22285858
Curr Drug Targets. 2000 Jul;1(1):25-58
pubmed: 11475535
Cell Death Dis. 2018 Feb 2;9(2):151
pubmed: 29396446
Tumour Biol. 2015 Jan;36(1):111-9
pubmed: 25464861
Semin Cancer Biol. 2012 Oct;22(5-6):446-54
pubmed: 22548724
Oncotarget. 2017 May 23;8(21):35103-35115
pubmed: 28402272
Mol Cell Biol. 2000 Dec;20(23):9041-54
pubmed: 11074002
J Clin Invest. 2009 Nov;119(11):3408-19
pubmed: 19841536
Oral Oncol. 2018 May;80:23-32
pubmed: 29706185
Chem Biol. 2013 Apr 18;20(4):604-13
pubmed: 23601649
J Clin Oncol. 2009 Apr 10;27(11):1806-13
pubmed: 19273710
Annu Rev Biochem. 2004;73:355-82
pubmed: 15189146
Mol Ther Oncolytics. 2017 May 10;5:87-96
pubmed: 28812060
J Cell Physiol. 2019 May;234(5):6263-6273
pubmed: 30246389
Cancer Sci. 2007 Oct;98(10):1512-20
pubmed: 17645776
Nat Rev Cancer. 2003 Nov;3(11):807-21
pubmed: 14557817
Clin Cancer Res. 2019 May 1;25(9):2887-2899
pubmed: 30705034
J Natl Cancer Inst. 2013 Jun 19;105(12):887-98
pubmed: 23704280
Clin Cancer Res. 2011 Aug 15;17(16):5402-11
pubmed: 21705453
Mol Ther. 2017 Mar 1;25(3):666-678
pubmed: 28143738
Toxicol Appl Pharmacol. 2018 Apr 15;345:1-9
pubmed: 29524504
Int J Food Microbiol. 2014 Mar 17;174:47-55
pubmed: 24457153
Chem Pharm Bull (Tokyo). 1987 Jul;35(7):3016-20
pubmed: 3677249
Transl Oncol. 2015 Feb;8(1):18-24
pubmed: 25749173
Cell Res. 2009 Feb;19(2):156-72
pubmed: 19153598
Phytother Res. 2007 Nov;21(11):1061-5
pubmed: 17639553
Chem Biol. 2009 Feb 27;16(2):133-40
pubmed: 19246003
J Biol Chem. 2003 May 23;278(21):18714-9
pubmed: 12621041
Cancer Biol Ther. 2002 May-Jun;1(3):237-42
pubmed: 12432270
Chemotherapy. 2010;56(5):393-402
pubmed: 20948210
Basic Clin Pharmacol Toxicol. 2008 May;102(5):419-25
pubmed: 18346055
Nat Rev Cancer. 2009 Apr;9(4):265-73
pubmed: 19262571
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Biochem Biophys Res Commun. 2018 Mar 25;498(1):246-253
pubmed: 29353042
Oral Maxillofac Surg. 2012 Jun;16(2):189-96
pubmed: 22592457
Toxicol Lett. 2009 Jun 22;187(3):131-6
pubmed: 19429255
Oncotarget. 2015 Aug 28;6(25):20993-1003
pubmed: 25895130
Clin Cancer Res. 2005 May 1;11(9):3191-7
pubmed: 15867212
Clin Cancer Res. 2002 Nov;8(11):3628-38
pubmed: 12429655
Oncogene. 2005 Aug 29;24(37):5764-74
pubmed: 16123809
Oncol Rep. 2008 Nov;20(5):1041-5
pubmed: 18949399